CAS 1639208-54-0
:Valbenazine tosylate
Description:
Valbenazine tosylate is a pharmaceutical compound primarily used in the treatment of tardive dyskinesia, a movement disorder often associated with long-term use of antipsychotic medications. It functions as a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, which helps to regulate the release of neurotransmitters, particularly dopamine, in the brain. This mechanism is crucial for alleviating the involuntary movements characteristic of the disorder. Valbenazine tosylate is typically administered orally and is known for its relatively favorable side effect profile compared to other treatments for movement disorders. The compound is characterized by its solubility in organic solvents and has a specific molecular structure that contributes to its pharmacological activity. As with many medications, it is essential to monitor for potential side effects, including sedation and other neurological effects. Overall, Valbenazine tosylate represents a significant advancement in the management of tardive dyskinesia, providing patients with a targeted therapeutic option.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Valbenazine tosylate
CAS:<p>Valbenazine tosylate is a drug that acts as an inhibitor. It is used in the treatment of Tourette syndrome, a disorder characterized by involuntary movements, vocalizations, or thoughts called tics. Valbenazine tosylate inhibits the enzyme monoamine oxidase-A (MAO-A), which affects dopamine levels in the brain. This drug has been shown to be effective for treating Tourette syndrome in patients with hepatic impairment and those who are obese. The side effects of this drug include nausea, vomiting, headache, and dizziness. Valbenazine tosylate may also cause dyskinesia, which is characterized by involuntary movements of the face and extremities.</p>Formula:C38H54N2O10S2Purity:Min. 95%Molecular weight:763 g/molValbenazine tosylate
CAS:<p>Valbenazine tosylate, the tosylate salt of valbenazine, is a vesicular monoamine transporter 2 (VMAT2) inhibitor with a Ki value of 150 nM while displaying no</p>Formula:C38H54N2O10S2Purity:98%Color and Shape:SolidMolecular weight:762.97
